Novai, a biotechnology startup originating from University College London, has secured £500,000 in seed funding in a round led by SFC Capital. The funding will be used to further develop Novai’s AI-powered technology that enables standard medical imaging equipment to identify eye disease at a cellular level up to 18 months earlier than current gold-standard processes.